These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20351559)

  • 1. Trends in retention on antiretroviral therapy in national programs in low-income and middle-income countries.
    Tassie JM; Baijal P; Vitoria MA; Alisalad A; Crowley SP; Souteyrand Y
    J Acquir Immune Defic Syndr; 2010 Aug; 54(4):437-41. PubMed ID: 20351559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review.
    Rosen S; Fox MP; Gill CJ
    PLoS Med; 2007 Oct; 4(10):e298. PubMed ID: 17941716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculosis in Pediatric Antiretroviral Therapy Programs in Low- and Middle-Income Countries: Diagnosis and Screening Practices.
    Ballif M; Renner L; Claude Dusingize J; Leroy V; Ayaya S; Wools-Kaloustian K; Cortes CP; McGowan CC; Graber C; Mandalakas AM; Mofenson LM; Egger M; Kumara Wati KD; Nallusamy R; Reubenson G; Davies MA; Fenner L; ;
    J Pediatric Infect Dis Soc; 2015 Mar; 4(1):30-8. PubMed ID: 26407355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review of retention of pediatric patients on HIV treatment in low and middle-income countries 2008-2013.
    Fox MP; Rosen S
    AIDS; 2015 Feb; 29(4):493-502. PubMed ID: 25565496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to antiretroviral therapy for HIV in sub-Saharan Africa and Asia: a comparative analysis of two regional cohorts.
    Bijker R; Jiamsakul A; Kityo C; Kiertiburanakul S; Siwale M; Phanuphak P; Akanmu S; Chaiwarith R; Wit FW; Sim BL; Boender TS; Ditangco R; Rinke De Wit TF; Sohn AH; Hamers RL
    J Int AIDS Soc; 2017 Mar; 20(1):21218. PubMed ID: 28362063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of three sampling methods to monitor outcomes of antiretroviral treatment programmes in low- and middle-income countries.
    Tassie JM; Malateste K; Pujades-Rodríguez M; Poulet E; Bennett D; Harries A; Mahy M; Schechter M; Souteyrand Y; Dabis F;
    PLoS One; 2010 Nov; 5(11):e13899. PubMed ID: 21085709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retention of Adult Patients on Antiretroviral Therapy in Low- and Middle-Income Countries: Systematic Review and Meta-analysis 2008-2013.
    Fox MP; Rosen S
    J Acquir Immune Defic Syndr; 2015 May; 69(1):98-108. PubMed ID: 25942461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marked sex differences in all-cause mortality on antiretroviral therapy in low- and middle-income countries: a systematic review and meta-analysis.
    Beckham SW; Beyrer C; Luckow P; Doherty M; Negussie EK; Baral SD
    J Int AIDS Soc; 2016; 19(1):21106. PubMed ID: 27834182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global estimates of HIV infections and AIDS cases: 1991.
    Chin J
    AIDS; 1991; 5 Suppl 2():S57-61. PubMed ID: 1845061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretroviral therapy outcomes in resource-limited settings for HIV-infected children <5 years of age.
    Sauvageot D; Schaefer M; Olson D; Pujades-Rodriguez M; O'Brien DP
    Pediatrics; 2010 May; 125(5):e1039-47. PubMed ID: 20385636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review.
    Fox MP; Rosen S
    Trop Med Int Health; 2010 Jun; 15 Suppl 1(s1):1-15. PubMed ID: 20586956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment and disease outcomes of migrants from low- and middle-income countries in the Australian HIV Observational Database cohort.
    Tilley DM; Griggs E; Hoy J; Wright ST; Woolley I; Burke M; O'Connor CC;
    AIDS Care; 2015; 27(11):1410-7. PubMed ID: 26679270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initiating Antiretroviral Therapy for HIV at a Patient's First Clinic Visit: The RapIT Randomized Controlled Trial.
    Rosen S; Maskew M; Fox MP; Nyoni C; Mongwenyana C; Malete G; Sanne I; Bokaba D; Sauls C; Rohr J; Long L
    PLoS Med; 2016 May; 13(5):e1002015. PubMed ID: 27163694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One world, one hope: the cost of providing antiretroviral therapy to all nations.
    Hogg RS; Weber AE; Craib KJ; Anis AH; O'Shaughnessy MV; Schechter MT; Montaner JS
    AIDS; 1998 Nov; 12(16):2203-9. PubMed ID: 9833862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.
    Ciaffi L; Koulla-Shiro S; Sawadogo AB; Ndour CT; Eymard-Duvernay S; Mbouyap PR; Ayangma L; Zoungrana J; Gueye NFN; Diallo M; Izard S; Bado G; Kane CT; Aghokeng AF; Peeters M; Girard PM; Le Moing V; Reynes J; Delaporte E;
    Lancet HIV; 2017 Sep; 4(9):e384-e392. PubMed ID: 28566227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global oral inequalities in HIV infection.
    Challacombe SJ
    Oral Dis; 2016 Apr; 22 Suppl 1():35-41. PubMed ID: 27109270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa, 2002-2013: a meta-analysis.
    Siedner MJ; Ng CK; Bassett IV; Katz IT; Bangsberg DR; Tsai AC
    Clin Infect Dis; 2015 Apr; 60(7):1120-7. PubMed ID: 25516189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-transfer and mortality amongst adults lost to follow-up in ART programmes in low- and middle-income countries: systematic review and meta-analysis.
    Wilkinson LS; Skordis-Worrall J; Ajose O; Ford N
    Trop Med Int Health; 2015 Mar; 20(3):365-79. PubMed ID: 25418366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
    Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D;
    AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Global AIDS epidemic: from epidemiology to universal treatment].
    Anglaret X
    Rev Med Interne; 2008 Dec; 29 Suppl 3():S269-73. PubMed ID: 18996627
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.